speechpfizer clinical research unit new haven ctShare on FacebookShare on Twitter168IMAGESCOVID-19: Pfizer's vaccine candidate shown to be 90% effectivePfizer Says Covid-19 Vaccine Late-Stage Trial Almost Fully EnrolledClinical Research UnitPfizer to acquire New Haven migraine drugmaker Biohaven for $11.6 billionNew Haven chosen as research center by German instituteAndover, Massachusetts
IMAGES